Pure Global AI
ANVISA registration 81062710054Valid until Aug 07, 2033

MONITORAMENTO DE CARGA VIRAL – VÍRUS DE IMUNODEFICIÊNCIA HUMANA TIPO 1 (HIV-1)

ANVISA Registration Number: 81062710054Cepheid Brasil Importação, Exportação e Comércio de Produtos de Diagnósticos ltdaCEPHEID ABRisk Class III
Device names
Technical name
MONITORAMENTO DE CARGA VIRAL – VÍRUS DE IMUNODEFICIÊNCIA HUMANA TIPO 1 (HIV-1)
Commercial name
Xpert® HIV-1 Viral Load XC
Risk class
Class III
Registration details
Registration Number
81062710054
Process Number
25351353841202281
CNPJ
18628083000123
Company information
Manufacturer
CEPHEID AB
Manufacturing Country
Sweden
PT: SUÉCIA
Dates and status
Publication Date
Aug 07, 2023
Validity
07/08/2033
Last Updated
08/18/2026 19:00:00
About this record

Access comprehensive regulatory information for MONITORAMENTO DE CARGA VIRAL – VÍRUS DE IMUNODEFICIÊNCIA HUMANA TIPO 1 (HIV-1) in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 81062710054 and manufactured by CEPHEID AB. The registration is held by Cepheid Brasil Importação, Exportação e Comércio de Produtos de Diagnósticos ltda with validity until Aug 07, 2033.

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.